VEGF inhibitors in cancer therapy

AR Cardones, LL Banez - Current pharmaceutical design, 2006 - ingentaconnect.com
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is thought to play a
critical role in tumor growth and metastasis. Consequently, anti-VEGF therapies are being …
被引用次数：165 相关文章

VEGF Inhibitors in Cancer Therapy

AR Cardones, LL Banez - Current Pharmaceutical Design, 2006 - search.proquest.com
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is thought to play a
critical role in tumor growth and metastasis. Consequently, anti-VEGF therapies are being …

[引用][C] VEGF inhibitors in cancer therapy

AR CARDONES, LL BANEZ - Current pharmaceutical design, 2006 - pascal-francis.inist.fr
VEGF inhibitors in cancer therapy CNRS Inist Pascal-Francis CNRS Pascal and Francis
Bibliographic Databases Simple search Advanced search Search by classification Search …

VEGF inhibitors in cancer therapy.

AR Cardones, LL Banez - Current Pharmaceutical Design, 2006 - europepmc.org
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is thought to play a
critical role in tumor growth and metastasis. Consequently, anti-VEGF therapies are being …

VEGF inhibitors in cancer therapy

AR Cardones, LL Banez - Current pharmaceutical design, 2006 - pubmed.ncbi.nlm.nih.gov
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is thought to play a
critical role in tumor growth and metastasis. Consequently, anti-VEGF therapies are being …

[引用][C] VEGF inhibitors in cancer therapy

AR CARDONES, LL BANEZ - Current pharmaceutical design, 2006 - Bentham